Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction
Clinical trial NCT05212610 · COMPLETED
Trial details
- NCT number
- NCT05212610
- Sponsor
- University of Michigan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-21
- Primary completion
- 2025-03-07
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.